Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Infections × Voriconazole × Clear all

Phase

Status

Completed 4 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 1 Invasive Pulmonary Aspergillosis 1 Invasive Fungal Infections 1 Infections 1 Hematologic Neoplasms 1 Haematological Malignancies 1

Interventions

Moxifloxacin 2 Ciprofloxacin 2 telaprevir 1 peginterferon alfa-2a 1 Voriconazole 1 Ribavirin 1 Negative-Pressure Wound Therapy 1 Immunosuppression Therapy 1 Diet 1 Cone-Beam Computed Tomography 1 Caspofungin 1 Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00238355 2025-04-27

Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems

OHSU Knight Cancer Institute

Phase 2 Terminated

13 enrolled 8 charts

Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡